The 7th Drug-Device Combination Products Summit brings together drug delivery and device development experts to explore the evolving landscape of combination products. Jakob Lange of Ypsomed will speak on how delivery systems for obesity therapies must balance convenience, cost, and sustainability, all key factors shaping patient experience and product success.
Berlin sets the stage this September for discussions on sustainability, patient needs, and regulatory alignment. Join us and be part of the conversation.
Our speaker at the conference
Jakob Lange
Jakob Lange is currently VP and head of Account and Business Development with responsibility for Ypsomed's customer relationships and marketing activities. Before his present role, he held different positions within marketing and sales as well as in R&D project management. He has been with Ypsomed for more than 19 years. Jakob holds an MSc degree in Chemical Engineering from the Royal Institute of Technology in Stockholm, Sweden, and a Ph.D. in Polymer Science from the Swiss Federal Institute of Technology in Lausanne, Switzerland. He has written and published more than 40 peer-reviewed papers on medical devices, packaging materials, and polymers.
